Mortality [qnco]
CARDIOVASCULAR [bdsy]
DPP IV [aapp, enzy, imft]
Inhibitor [qlco]
sitagliptin [orch, phsu]
Compared [acty]
Metformin [orch, phsu]
retrospective [resa]
Cohort Study [qnco]
Performed [ftcn]
Retrospective Cohort Study [resa]
investigating [ftcn]
Including [ftcn]
Mortality [qnco]
Cardiovascular disease [dsyn]
sitagliptin [orch, phsu]
Compared [acty]
Metformin [orch, phsu]
Patients [podg]
Receive [qlco]
Dipeptidyl-Peptidase IV Inhibitors [phsu]
DPP IV [aapp, enzy, imft]
Inhibitor [qlco]
sitagliptin [orch, phsu]
Identified [qlco]
Mortality [qnco]
Composite [qlco]
End Point [qlco]
Stroke [dsyn]
Acute myocardial infarction [dsyn]
Mortality [qnco]
sitagliptin [orch, phsu]
Compared [acty]
Metformin [orch, phsu]
Addition [ftcn]
indicator [irda]
Efficacy [qlco]
Hazard Ratio [qnco]
Changing [ftcn]
treatment [ftcn]
Patients [podg]
included [ftcn]
Received [qlco]
sitagliptin [orch, phsu]
Remaining [qlco]
Patients [podg]
Received [qlco]
Metformin [orch, phsu]
Patients [podg]
Metformin [orch, phsu]
Young [tmco]
Patients [podg]
sitagliptin [orch, phsu]
Often [tmco]
Long duration [qlco]
treatment [ftcn]
Compared [acty]
Patients [podg]
Receive [qlco]
Metformin [orch, phsu]
Patients [podg]
sitagliptin [orch, phsu]
statistically significant [qnco]
Excess [qlco]
Risks [qlco]
Mortality [qnco]
Hazard Ratio [qnco]
P NOS [aapp, imft]
Composite [qlco]
End Point [qlco]
Hazard Ratio [qnco]
P NOS [aapp, imft]
sitagliptin [orch, phsu]
Increased [qnco]
Likelihood [qnco]
Changing [ftcn]
treatment [ftcn]
Hazard Ratio [qnco]
4 5 [qnco]
P NOS [aapp, imft]
P NOS [aapp, imft]
Id [idcn]
Para [fndg]
retrospective [resa]
sitagliptin [orch, phsu]
Compared [acty]
Metformin [orch, phsu]
Statistical Significance [qnco]
Increased [qnco]
Mortality [qnco]
Composite [qlco]
End Point [qlco]
Increased [qnco]
Likelihood [qnco]
Changing [ftcn]
Glucose [bacs, carb, phsu]
lowering [spco]
treatment [ftcn]
